Jerome Wong is CFO at EKSO BIONICS HOLDINGS, INC. (EKSO). They have made 7 open-market trades across 1 company since 2022, most recently 2026-08-16.
CIK 0001932326
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2026, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EKSO | 4,184 | $48K |
| CHRN | 364,771 | — |
| Total | $48K |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EKSO | BUY | 2026-03-16 | 2026-03-20 | $11.85 | $15K | -4.7% | -0.4% | N/A |
| EKSO | SELL | 2025-12-09 | 2025-12-10 | $4.70 | $6K | +10.5% | +66.2% | +160.0% |
| EKSO | SELL | 2025-11-10 | 2025-11-12 | $4.80 | $108K | -21.9% | -13.5% | +82.2% |
| EKSO | SELL | 2023-08-17 | 2023-08-18 | $1.00 | $13K | +0.4% | -19.8% | +53.6% |
| EKSO | SELL | 2022-11-16 | 2022-11-17 | $1.28 | $925 | -23.0% | -1.5% | +27.3% |
| EKSO | SELL | 2022-08-03 | 2022-08-04 | $1.80 | $3K | +22.8% | +13.3% | -16.4% |
| EKSO | SELL | 2022-07-18 | 2022-07-20 | $1.71 | $168 | -2.8% | +26.7% | -20.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.